Aging biomarkers are a combination of biological parameters to (i) assess age-related
changes,(ii) track the physiological aging process, and (iii) predict the transition into a …

Background Impressive progress in the understanding of the prodromal phase of
Parkinson's disease (PD) in recent years has enabled the generation of disease prediction …

Biomarkers for predicting Alzheimer's disease (AD) are advancing and their implementation
in various healthcare systems is imminent. There is a need for ethical standards addressing …

Introduction: Dementia is a condition (a collection of related signs and symptoms) that
causes a continuing deterioration in cognitive function, and millions of people are impacted …

The risk of developing chronic illnesses and disabilities is increasing with age. To predict
and prevent aging, biomarkers relevant to the aging process must be identified. This paper …

The diagnosis, treatment, and management of dementia provide significant challenges due
to its chronic cognitive impairment. The complexity of this condition is further highlighted by …

New possibilities of biomarker‐based predictive technologies for Alzheimer's disease (AD)
have become more reliable as well as more accessible. Standardized clinical …

The prevention of dementia is increasingly a task for public health promotion and aims at the
general public. This likewise holds for potentially modifiable lifestyle risk factors and …

Advances in biomarkers, genetics, and other data used as dementia risk evidence (DRE)
are increasingly informing clinical diagnosis and management. The purpose of this Mini …

INTRODUCTION The development of biomarkers for Alzheimer's disease (AD) has allowed
researchers to increase sample homogeneity and test candidate treatments earlier in the …